Crinetics Pharmaceuticals has recently made headlines with their successful private placement of 8,333,334 shares of common stock at $42.00 per...

On February 28, 2024, Novavax (NASDAQ: NVAX) released its fourth-quarter financial results, revealing a loss of $(1.44) per share. This...

vTv Therapeutics made headlines on February 28, 2024, with the announcement of a significant $51 million private placement from prominent...

Obesity is a prevalent global issue, affecting millions of individuals worldwide. It is characterized by chronic inflammation, which can lead...

Arcutis Biotherapeutics (NASDAQ: ARQT) has been garnering attention from analysts in recent months, with a noticeable uptick in price targets....

After analyzing the opinions of 7 analysts, Arvinas (NASDAQ: ARVN) has received a mix of ratings ranging from bullish to...

Deepwater Asset Management's managing partner, Gene Munster, was taken aback and disheartened by Apple's surprising choice to scrap its electric...

Microsoft's Copilot AI chatbot has once again caught users by surprise with a mysterious alter ego named "Sydney," who has...

Wedbush analyst Laura Chico has once again backed Denali Therapeutics (NASDAQ: DNLI) with an Outperform rating and a $31 price...

On February 28, 2024, Francois Brisebois, an analyst at Oppenheimer, once again expressed confidence in Tarsus Pharmaceuticals, giving it an...